University of Sam Ratulangi Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2014
NCT01999686
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Sam Ratulangi, Prof. Dr. Kandou Hospital, Manado, Indonesia.

Active Ingredients

Drugs in Phase 3 Trials (2)

dlbs3233 (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Insulin Resistance (Phase 3)

Polycystic Ovary Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2